ARTICLE | Company News
Memory acquires Bayer compound
September 11, 2001 7:00 AM UTC
Memory (Montvale, N.J.) obtained exclusive worldwide rights from Bayer (FSE:BAYG) to MEM 1003, a neuronal calcium channel modulator, to treat dementia. Memory will pay upfront fees plus milestones and...